Sanofi arbeitet mit OpenAI und Formation Bio an der KI-gesteuerten Arzneimittelentwicklung zusammen

    https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-partners-with-openai-formation-bio-ai-driven-drug-development-2024-05-21/

    Share.

    1 Kommentar

    1. > French drugmaker Sanofi on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial Intelligence.

      > Sanofi said in a statement that the partnership with OpenAi will allow it to access proprietary data to develop AI models for its biopharma models, while Formation Bio will provide additional engineering resources.

    Leave A Reply